A carregar...

Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels

AIM: Retigabine, an activator of KCNQ2-5 channels, is currently used to treat partial-onset seizures. The aim of this study was to explore the possibility that structure modification of retigabine could lead to novel inhibitors of KCNQ2 channels, which were valuable tools for KCNQ channel studies. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, Hai-ning, Zhou, Ping-zheng, Chen, Fei, Li, Min, Nan, Fa-jun, Gao, Zhao-bing
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002159/
https://ncbi.nlm.nih.gov/pubmed/23933653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2013.79
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!